top of page

2016. Medical Treatments in Patients with Primary Sclerosing Cholangitis Differ Between Europe and North America

Poster and abstract presented at EASL International Liver Congress 2016

Authors: Gomel, Rachel & Safer, R. & Lindor, Keith & Everson, Gregory & Bowlus, C

Journal: Journal of Hepatology. 64. S641. 10.1016/S0168-8278(16)01194-6.


"Conclusions:  Treatment of PSC and concomitant IBD differs between Europe and NA and is not accounted for by differences in disease characteristics. Medication differences may need to be considered in studies of disease progression."

Data from PSC Partners Patient Registry

bottom of page